Skyrizi 360 MG/2.4 ML on-body 2.4ML

Ended Awarded

Contract number
SPE2DR26F5TT9
Awardee
Awarding agency
Obligated
$12,467

Award facts

Contract value 100% obligated
$12,467.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Conshohocken, PA 19428, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Logistics Agency issued a $12,467 delivery order to Amerisourcebergen Drug Corp on July 1, 2026, for SKYRIZI 360 mg/2.4 ml on-body injectables with an ultimate completion date of July 23, 2026.

Place of performance is Conshohocken, PA. The order is firm fixed-price with no set-aside. Amerisourcebergen, a pharmaceutical distributor and medical supplier subsidiary of Cencora, Inc., holds a single-award indefinite delivery contract (SPE2DX) with DLA Troop Support Medical valued at $4.999 million through December 2036, supporting the Pharmaceutical Prime Vendor Global Program Generation V for worldwide military healthcare supply.

Quick answers

Who was awarded contract SPE2DR26F5TT9?

SPE2DR26F5TT9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 1, 2026.

How much is contract SPE2DR26F5TT9 worth?

The government has obligated $12,467 on SPE2DR26F5TT9.

Is contract SPE2DR26F5TT9 an order under another contract?

Yes. SPE2DR26F5TT9 is a delivery order under SPE2DR25D3003, an indefinite delivery contract.

Was contract SPE2DR26F5TT9 competed?

The extent of competition for SPE2DR26F5TT9 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award